Greenwich LifeSciences
GLSI
46 hedge funds and large institutions have $11.1M invested in Greenwich LifeSciences in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
10% more funds holding
Funds holding: 42 → 46 (+4)
0.14% less ownership
Funds ownership: 8.98% → 8.84% (-0.14%)
16% less capital invested
Capital invested by funds: $13.3M → $11.1M (-$2.18M)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$187K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$161K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$38.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.6K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$30.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$169K |
| 2 |
Renaissance Technologies
New York
|
-$124K |
| 3 |
BlackRock
New York
|
-$68.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$56.8K |
| 5 |
Morgan Stanley
New York
|
-$51.3K |
GLSI Hedge Fund Activity: Q1 2025 in Review
46 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q1 2025, worth a combined $11.1M — down 16% from $13.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GLSI positions and 2 closed out — a net gain of 5 holders — while 9 added to existing stakes and 13 trimmed.
The largest buyer was HighTower Advisors, opening a new position worth an estimated $187K. The largest seller was Goldman Sachs, exiting entirely with an estimated $169K sold.
- 46 institutional investors held Greenwich LifeSciences (GLSI) as of Q1 2025, up from 42 in Q4 2024.
- Funds reported $11.1M of Greenwich LifeSciences stock for Q1 2025, down 16% quarter-over-quarter.
- 7 funds opened new Greenwich LifeSciences positions in Q1 2025 and 2 closed out, a net change of +5 holders.
- The largest Greenwich LifeSciences buyer in Q1 2025 was HighTower Advisors, an estimated $187K added.
- The largest Greenwich LifeSciences seller in Q1 2025 was Goldman Sachs, an estimated $169K sold.
Based on aggregated 13F filings for Q1 2025.